Furthermore, higher IL-36α expression levels were observed in patients with CRS and nasal polyps in the refractory group, when compared to the control group, and the increase in IL-36α expression and neutrophil inflammation were considered as risk factors for refractory in human CRS patients (51). Here, IL36A is linked to nasal cavity polyp.